[Guillain-Barré syndrome of axonal type, Campylobacter jejuni infection and anti-ganglioside GM1 antibodies]. 1997

S Attarian, and B Bonnefoi-Kyriacou, and D Gayraud, and P Mignard, and J Boucraut, and J Pouget, and F Viallet
Service de Neurologie, CHG d'Aix-en-Provence.

Infection by Campylobacter jejuni (C. jejuni) has been reported in 17 to 55 p. 100 of the GBS. The "axonal" GBS has been recently attributed to such an association. It is characterized by rapid progression to severe widespread paralysis, respiratory failure, poor and delayed recovery. The acute "axonal" form of Guillain-Barré syndrome has been and remains a matter of controversy. A typical case of GBS with serological evidence of recent C. jejuni infection and increased antibodies to GM1 is reported. An immune mechanism remains most likely. Recent studies have suggested the hypothesis of "shared epitope" between C. jejuni and peripheral nervous system cell (Gal beta 1-3 N Acetylgalactosamine epitope). Such a cross-reactivity could provoke a severe form of GBS with a poor recovery in some predisposed hosts (antiganglioside antibodies, HLA "immunogenic" groups such as B8, B35 or DR3).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011129 Polyradiculoneuropathy Diseases characterized by injury or dysfunction involving multiple peripheral nerves and nerve roots. The process may primarily affect myelin or nerve axons. Two of the more common demyelinating forms are acute inflammatory polyradiculopathy (GUILLAIN-BARRE SYNDROME) and POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING. Polyradiculoneuritis refers to inflammation of multiple peripheral nerves and spinal nerve roots. Autoimmune Demyelinating Disease, Peripheral,Demyelinating Autoimmune Disease, Peripheral,Demyelinating Disease, Peripheral Autoimmune,Peripheral Autoimmune Demyelinating Disease,Polyradiculoneuritis,Polyradiculoneuritides,Polyradiculoneuropathies
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002169 Campylobacter Infections Infections with bacteria of the genus CAMPYLOBACTER. Campylobacter Infection,Campylobacteriosis,Infections, Campylobacter,Campylobacterioses,Infection, Campylobacter
D005677 G(M1) Ganglioside A specific monosialoganglioside that accumulates abnormally within the nervous system due to a deficiency of GM1-b-galactosidase, resulting in GM1 gangliosidosis. GM1 Ganglioside,Monosialosyl Tetraglycosyl Ceramide,GM1a Monosialoganglioside,Ceramide, Monosialosyl Tetraglycosyl,Ganglioside, GM1,Monosialoganglioside, GM1a,Tetraglycosyl Ceramide, Monosialosyl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D001369 Axons Nerve fibers that are capable of rapidly conducting impulses away from the neuron cell body. Axon
D016123 Campylobacter jejuni A species of bacteria that resemble small tightly coiled spirals. Its organisms are known to cause abortion in sheep and fever and enteritis in man and may be associated with enteric diseases of calves, lambs, and other animals. Campylobacter fetus subsp. jejuni,Vibrio hepaticus,Vibrio jejuni

Related Publications

S Attarian, and B Bonnefoi-Kyriacou, and D Gayraud, and P Mignard, and J Boucraut, and J Pouget, and F Viallet
November 1995, Annals of neurology,
S Attarian, and B Bonnefoi-Kyriacou, and D Gayraud, and P Mignard, and J Boucraut, and J Pouget, and F Viallet
October 2000, Annals of neurology,
S Attarian, and B Bonnefoi-Kyriacou, and D Gayraud, and P Mignard, and J Boucraut, and J Pouget, and F Viallet
January 2005, Srpski arhiv za celokupno lekarstvo,
S Attarian, and B Bonnefoi-Kyriacou, and D Gayraud, and P Mignard, and J Boucraut, and J Pouget, and F Viallet
August 1996, Annals of neurology,
S Attarian, and B Bonnefoi-Kyriacou, and D Gayraud, and P Mignard, and J Boucraut, and J Pouget, and F Viallet
August 1995, The Journal of infectious diseases,
S Attarian, and B Bonnefoi-Kyriacou, and D Gayraud, and P Mignard, and J Boucraut, and J Pouget, and F Viallet
January 1992, Muscle & nerve,
S Attarian, and B Bonnefoi-Kyriacou, and D Gayraud, and P Mignard, and J Boucraut, and J Pouget, and F Viallet
January 2018, BMJ case reports,
S Attarian, and B Bonnefoi-Kyriacou, and D Gayraud, and P Mignard, and J Boucraut, and J Pouget, and F Viallet
May 2000, Journal of neuroimmunology,
S Attarian, and B Bonnefoi-Kyriacou, and D Gayraud, and P Mignard, and J Boucraut, and J Pouget, and F Viallet
January 2010, Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg,
S Attarian, and B Bonnefoi-Kyriacou, and D Gayraud, and P Mignard, and J Boucraut, and J Pouget, and F Viallet
June 1990, Lancet (London, England),
Copied contents to your clipboard!